Literature DB >> 9491116

Comparison of the long-pulse dye (590-595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasias.

T B West1, T S Alster.   

Abstract

BACKGROUND: Telangiectasias develop on the face secondary to genetic predisposition, chronic actinic damage, collagen vascular disease, topical steroid application, and disorders of vascular regulation including acne rosacea. Linear and "spider" telangiectasias develop on the legs, especially in women beginning in the second to third decade, secondary to multiple factors including genetic predisposition, gravity, pregnancy, and trauma.
OBJECTIVE: The purpose of this investigation was to compare the 590- and 595-nm long-pulse (1.5 msec) dye laser and KTP (532 nm) laser in the treatment of facial and leg telangiectasias.
RESULTS: For both facial and lower extremity telangiectasias, the difference in improvement ratings between the two lasers following both one and two treatment sessions was statistically significant.
CONCLUSION: Both the flashlamp-pumped long-pulse dye laser and the KTP laser may play a role in the treatment of facial and leg telangiectasias. However, when used to treat vessels on the lower extremities, both of these laser systems are probably best used in conjunction with sclerotherapy of the larger "feeding" reticular veins. While long-pulse dye laser irradiation achieves superior vessel clearance, patients may prefer multiple treatments with the KTP laser due to its low side effect profile and decreased associated pain.

Entities:  

Mesh:

Year:  1998        PMID: 9491116     DOI: 10.1111/j.1524-4725.1998.tb04140.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  12 in total

Review 1.  [Lasers and aesthetic dermatology].

Authors:  A J Stratigos; J S Dover; K A Arndt
Journal:  Hautarzt       Date:  2003-06-12       Impact factor: 0.751

2.  A randomised, blinded, controlled study of the clinical relevance of matching pulse duration to thermal relaxation time when treating facial telangiectasia.

Authors:  Heather Cameron; Sally H Ibbotson; James Ferguson; Robert S Dawe; Harry Moseley
Journal:  Lasers Med Sci       Date:  2005-09-09       Impact factor: 3.161

3.  [Laser therapy for vascular lesions].

Authors:  B Greve; C Raulin
Journal:  Hautarzt       Date:  2006-06       Impact factor: 0.751

4.  Treatment of superficial vascular lesions with the KTP 532-nm laser: experience with 647 patients.

Authors:  G L Becher; H Cameron; H Moseley
Journal:  Lasers Med Sci       Date:  2013-04-30       Impact factor: 3.161

5.  Novel photopneumatic therapy for the treatment of rosacea.

Authors:  Jun Hyung Kim; Seung Ho Chang; Mi Kyung Cho; Bang Soon Kim
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

6.  Successful treatment of erythematotelangiectatic rosacea with pulsed light and radiofrequency.

Authors:  Amy Forman Taub; Erin C Devita
Journal:  J Clin Aesthet Dermatol       Date:  2008-05

7.  Treatment of superficial cutaneous vascular lesions: experience with the KTP 532 nm laser.

Authors:  C Clark; H Cameron; H Moseley; J Ferguson; S H Ibbotson
Journal:  Lasers Med Sci       Date:  2004-04-14       Impact factor: 3.161

Review 8.  Transcutaneous laser treatment of leg veins.

Authors:  Arne A Meesters; Luiza H U Pitassi; Valeria Campos; Albert Wolkerstorfer; Christine C Dierickx
Journal:  Lasers Med Sci       Date:  2013-11-13       Impact factor: 3.161

9.  Low energy KTP laser in oral soft tissue surgery: A 52 patients clinical study.

Authors:  C Fornaini; J-P Rocca; E Merigo; M Meleti; M Manfredi; S Nammour; P Vescovi
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-03-01

10.  Update on the management of rosacea.

Authors:  Allison P Weinkle; Vladyslava Doktor; Jason Emer
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.